Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Salkera Emollient Foam
Chongqing Precision Biotech Co., Ltd
Keratosis Pilaris
1 trial -
Salmeterol/Fluticasone Propionate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Salmeterol/fluticasone propionate or formoterol/budesonide
GlaxoSmithKline
Asthma
1 trial -
Salvianolate injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Angina
1 trial -
Sarilumab
Regeneron UK Limited
Polymyalgia Rheumatica
1 trial -
Sarilumab
Regeneron UK Limited
Rheumatoid Arthritis
8 trials -
Sativex
Jazz Pharmaceuticals Ireland Limited
Multiple Sclerosis
2 trials -
Satralizumab 120 mg
Hoffmann-La Roche
Neuromyelitis Optica Spectrum Disorder
1 trial -
Saussurea Involucrata Liquid Tonic
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postpartum Rheumatism
1 trial -
Sb 241
Biocodex
Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))
1 trial -
Scheduled Gradual Reduction + Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Addiction
1 trial -
Search AV+ algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmia, Sinus
1 trial -
Secukinumab s.c. injection
Novartis Pharmaceuticals
Autoimmunity, Inflammation
1 trial -
Selective serotonin reuptake inhibitor (SSRI)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anxiety Depression
1 trial -
Semaglutide
United Therapeutics Europe Ltd
Obesity
1 trial -
Semaglutide B 3.0 mg/ml PDS290
Disc Medicine
obesity
1 trial -
Sequential Icotinib Plus Chemotherapy
Betta Pharmaceuticals Co.,
EGFR Positive Non-small Cell Lung Cancer
1 trial -
Sertraline
United Therapeutics Europe Ltd
Generalised Anxiety Disorder
1 trial -
Sertraline
The First People's Hospital of Lianyungang
Efficacy, Team
1 trial -
Sertraline Hydrochloride
The First People's Hospital of Lianyungang
COVID-19 Vaccine Adverse Reaction
1 trial -
Sesame Oil
United Therapeutics Europe Ltd
Caloric Restriction
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
Sevelamer
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Degenerative Heart Valve Disease
1 trial -
Sevoflurane
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Middle Aged Patients
1 trial -
Sevoflurane
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intra-abdominal and Intrapelvic Surgery
1 trial -
Sham (Comparator) Plasma Ball
United Therapeutics Europe Ltd
Phantom Limb Pain
1 trial -
Sham Injection
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
Sanofi Pasteur
Cholera
1 trial -
Shared Solutions® plus MS Center v. Shared Solutions®
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
Shenfu Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Cardiomyopathy
1 trial -
Shenfu Injection
The First People's Hospital of Lianyungang
Septic Shock
2 trials -
Shenfu Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Myocardial Infarction
1 trial -
Shenling Baizhu granules (TCM patent medicine)
Universal Integrated
Low-risk Colorectal Adenoma
1 trial -
Shenlingcao Oral Liquid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Non-Small-Cell Lung
1 trial -
Shexiang Baoxin pill
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease(CAD)
1 trial -
Shexiang Baoxin pill(MUSKARDIA)
Disc Medicine
Ischemia With Non-Obstructive Coronary Artery
1 trial -
Short Cycle Antiretroviral Therapy
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Sildenafil citrate
Pfizer
Pulmonary Arterial Hypertension
1 trial -
Silver Sulfadiazine
United Therapeutics Europe Ltd
Superficial Partial Thickness Burn
1 trial -
Simethicone
Hospital Authority, Hong Kong
Colonoscopy
1 trial -
Simvastatin
Hospital Authority, Hong Kong
Obesity
1 trial -
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Antiphospholipid (aPL)-Positive
1 trial -
Sitagliptin
Chen Suning
Type 2 Diabetes
1 trial -
Skin stretching device (SSD)
The First People's Hospital of Lianyungang
Trauma
1 trial -
Sobi.BIVV001-004
Swedish Orphan Biovitrum AB (publ)
Haemophilia A
1 trial -
Sobi.BIVV001-005
Swedish Orphan Biovitrum AB (publ)
Haemophilia A
1 trial -
Sodium Bicarbonate Ringer's Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Shock
1 trial -
Sodium Chloride 0.9% for Vulvar High-Grade Squamous Intr…
Disc Medicine
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.